|
Post by goyocafe on May 2, 2019 19:58:48 GMT -5
Bad Mgmt? This is a new Mgmt team with less than 3 yrs piecing the EOR line every has held onto pre PF CEO Make no mistake, if a replacement CEO came in tomorrow, many of these same voices would simply throw a name swap to the criticism they levy. Some have honest issues, others will not stop until the Company is destroyed. I suggest it will also stop if and when the company performs to even modest expectations.
|
|
|
Post by longliner on May 2, 2019 20:02:15 GMT -5
Make no mistake, if a replacement CEO came in tomorrow, many of these same voices would simply throw a name swap to the criticism they levy. Some have honest issues, others will not stop until the Company is destroyed. I suggest it will also stop if and when the company performs to even modest expectations. Possibly, it depends on who they work for...
|
|
|
Post by akemp3000 on May 2, 2019 20:08:29 GMT -5
While some of the criticism comes from long-term investors, it's likely the more volatile criticism and calls for big change comes from either short-term traders or moles. Just wanted to share this perspective along with the obvious that good companies aren't managed for short-term results. IMO, Mike will get us to where we want to go. He certainly hasn't had an easy job.
|
|
|
Post by blueice on May 2, 2019 20:10:01 GMT -5
I suggest it will also stop if and when the company performs to even modest expectations. Possibly, it depends on who they work for... I work for me. In a market of 30M+ diabetics and a world of 400M diabetics, if the strategy is to convert them a handful at a time, we are doing awesome. You can enjoy your dream of Vegas, but the current plan will never get you there. However, if you stay tuned, your great, great, great grand kids might get to enjoy the Strip at the current pace. The company needs to move mountains when it is currently focused on grains of sand.
|
|
|
Post by longliner on May 2, 2019 20:13:25 GMT -5
Possibly, it depends on who they work for... I work for me. In a market of 30M+ diabetics and a world of 400M diabetics, if the strategy is to convert them a handful at a time, we are doing awesome. You can enjoy your dream of Vegas, but the current plan will never get you there. However, if you stay tuned, your great, great, great grand kids might get to enjoy the Strip at the current pace. The company needs to move mountains when it is currently focused on grains of sand. Never is a long time....still buying.
|
|
|
Post by blueice on May 2, 2019 20:19:52 GMT -5
I work for me. In a market of 30M+ diabetics and a world of 400M diabetics, if the strategy is to convert them a handful at a time, we are doing awesome. You can enjoy your dream of Vegas, but the current plan will never get you there. However, if you stay tuned, your great, great, great grand kids might get to enjoy the Strip at the current pace. The company needs to move mountains when it is currently focused on grains of sand. Never is a long time....still buying. I agree that never is a long time. Also, I will continue to buy when management delivers value that translates to investor trust. No "Q4 2018 Brazil approval"; no statements about "no need for dilution"; no December massacres due to drying liquidity markets; no "it's all up from here"; no "6-8 weeks for ads to show RX uplift". Give it to us straight and deliver like you say you always do. Incidentally, if management does turn this around, I will be in Vegas. I will be the guy eating a nice, fried crow which I want more than anything....
|
|
|
Post by lifebreath on May 2, 2019 20:23:16 GMT -5
I suggest it will also stop if and when the company performs to even modest expectations. Possibly, it depends on who they work for... I have owned stock in somewhere between 15 and 20 companies this is the first company I have been critical of the CEO. It is a horrible tragedy for diabetics and us long term shareholders that Kresa did not hire a seasoned veteran CEO of the pharma industry to move the company forward. My fellow shareholders whom are enamored with Castagna that is your prerogative, but at this point in time Castagna is just another ineffective CEO on the list since Alfred Mann turned over CEO responsibility to Hakan
|
|
|
Post by blueice on May 2, 2019 20:28:57 GMT -5
Possibly, it depends on who they work for... I have owned stock in somewhere between 15 and 20 companies this is the first company I have been critical of the CEO. It is a horrible tragedy for diabetics and us long term shareholders that Kresa did not hire a seasoned veteran CEO of the pharma industry to move the company forward. My fellow shareholders whom are enamored with Castagna that is your prerogative, but at this point in time Castagna is just another ineffective CEO on the list since Alfred Mann turned over CEO responsibility to Hakan Couldn't agree more. Castagna is a nice enough guy, but not the leader we need to bring the disruption that is needed in diabetic care (and care in general). We are fighting a war against incumbents and the establishment. A leader who will make change happen cannot make excuses as to why things are difficult. You keep hammering and make change happen.
|
|
|
Post by mytakeonit on May 2, 2019 20:47:32 GMT -5
Interesting that the same people are posting all day and just doing a rotation. Don't they have anything else to do? Maybe they should get a job ... or wake up later.
But, that's just mytakeonit
|
|
|
Post by joeypotsandpans on May 2, 2019 20:49:55 GMT -5
Joey, it seems you are overlooking a basic dynamic at play here. Many long time holders who you characterize as insane and "bitching year after year and continue to hold" - these long time holders believe in the phenomenal and unprecedented efficacy of Afrezza. And that belief grounds their investment. Why would they sell now as you suggest, with the share price in the tank? To the contrary, it is their right to continue holding, expecting the market to eventually figure it out. That does not mean they shouldn't be allowed to voice concerns in the way the company is being run. You don't have to agree with those concerns, it's a message board and so inherently everyone won't agree with each other. You're not the only one who does it Joey, but it isn't right for folks who post facts or opinions that aren't rosy and bubbly to be automatically labelled trolls or shorts. It's inaccurate and does this message board a disservice. I think you are overlooking the simplicity in my statement, If one understands the hand that was dealt to Al and the company, it could be any CEO and they wouldn't/couldn't be much more effective...all I am saying is that if you understand the situation you wouldn't be blaming it on MC or anyone else that was willing to take on the challenge that came with accepting the task. There are a lot of armchair quarterbacks on here that would be a lot better off changing the channel to another game. I fought tooth and nail to get my Afrezza, I know first hand the challenges I encountered...they were not because of the company, past management or current management, they were because of a criminal homicidal bitch that headed the FDA and her husband with no soul, the ruthless healthcare system we currently have, and some physicians/physician assistants that were either too lazy or inept to care. This current management did care and was instrumental in helping me get Afrezza, I'm not so sure another would have been, that is why I made the statement be careful what you wish for Most long term holders know who the trolls are on here, personally I think they have way too much time on their hands and should be using it for more productive things but hey that's their problem. I'm far less concerned about selfish shareholders and far more concerned about folks who should be getting a better treatment for their disease, I believe current management is of the same mindset.
|
|
|
Post by letitride on May 2, 2019 21:20:39 GMT -5
What we need is like a CEO of a multi billion dollar pharma to get this done. Oh wait hold up just a minute we had one and He gave up in 6 months. It takes more than a name and money to get something like this done. Its called foresight, patience, tenacity,and perseverance. Al Mann had those qualities and I cant think of a better fit to drive this home than Mike. Hes been on this but 2 years and this has done a 180. Our direction is clear as an investor I stand with Al Manns attributes. I had the foresight, ive been patient, and now im going to be tenacious in my stand with Mike in Mannkind. Will discuss persistence when we have won.
|
|
|
Post by blueice on May 2, 2019 21:24:10 GMT -5
Joey, it seems you are overlooking a basic dynamic at play here. Many long time holders who you characterize as insane and "bitching year after year and continue to hold" - these long time holders believe in the phenomenal and unprecedented efficacy of Afrezza. And that belief grounds their investment. Why would they sell now as you suggest, with the share price in the tank? To the contrary, it is their right to continue holding, expecting the market to eventually figure it out. That does not mean they shouldn't be allowed to voice concerns in the way the company is being run. You don't have to agree with those concerns, it's a message board and so inherently everyone won't agree with each other. You're not the only one who does it Joey, but it isn't right for folks who post facts or opinions that aren't rosy and bubbly to be automatically labelled trolls or shorts. It's inaccurate and does this message board a disservice. I think you are overlooking the simplicity in my statement, If one understands the hand that was dealt to Al and the company, it could be any CEO and they wouldn't/couldn't be much more effective...all I am saying is that if you understand the situation you wouldn't be blaming it on MC or anyone else that was willing to take on the challenge that came with accepting the task. There are a lot of armchair quarterbacks on here that would be a lot better off changing the channel to another game. I fought tooth and nail to get my Afrezza, I know first hand the challenges I encountered...they were not because of the company, past management or current management, they were because of a criminal homicidal bitch that headed the FDA and her husband with no soul, the ruthless healthcare system we currently have, and some physicians/physician assistants that were either too lazy or inept to care. This current management did care and was instrumental in helping me get Afrezza, I'm not so sure another would have been, that is why I made the statement be careful what you wish for Most long term holders know who the trolls are on here, personally I think they have way too much time on their hands and should be using it for more productive things but hey that's their problem. I'm far less concerned about selfish shareholders and far more concerned about folks who should be getting a better treatment for their disease, I believe current management is of the same mindset. It's great that you are getting the care you need and awesome that management helped. Also, if there are obstacles in other areas including the FDA, as a business, MKND needs to figure out quickly how, in a scalable manner, they can ensure a wider market of patients get the critical care they need. There are definitely obstacles, and it's management's responsibility to create a sustainable business model that addresses patient and investor value. If they don't figure it out, we go bust and that helps no one in the long term. Keep well.
|
|
|
Post by sellhighdrinklow on May 2, 2019 21:38:11 GMT -5
Joey, it seems you are overlooking a basic dynamic at play here. Many long time holders who you characterize as insane and "bitching year after year and continue to hold" - these long time holders believe in the phenomenal and unprecedented efficacy of Afrezza. And that belief grounds their investment. Why would they sell now as you suggest, with the share price in the tank? To the contrary, it is their right to continue holding, expecting the market to eventually figure it out. That does not mean they shouldn't be allowed to voice concerns in the way the company is being run. You don't have to agree with those concerns, it's a message board and so inherently everyone won't agree with each other. You're not the only one who does it Joey, but it isn't right for folks who post facts or opinions that aren't rosy and bubbly to be automatically labelled trolls or shorts. It's inaccurate and does this message board a disservice. I think you are overlooking the simplicity in my statement, If one understands the hand that was dealt to Al and the company, it could be any CEO and they wouldn't/couldn't be much more effective...all I am saying is that if you understand the situation you wouldn't be blaming it on MC or anyone else that was willing to take on the challenge that came with accepting the task. There are a lot of armchair quarterbacks on here that would be a lot better off changing the channel to another game. I fought tooth and nail to get my Afrezza, I know first hand the challenges I encountered...they were not because of the company, past management or current management, they were because of a criminal homicidal bitch that headed the FDA and her husband with no soul, the ruthless healthcare system we currently have, and some physicians/physician assistants that were either too lazy or inept to care. This current management did care and was instrumental in helping me get Afrezza, I'm not so sure another would have been, that is why I made the statement be careful what you wish for Most long term holders know who the trolls are on here, personally I think they have way too much time on their hands and should be using it for more productive things but hey that's their problem. I'm far less concerned about selfish shareholders and far more concerned about folks who should be getting a better treatment for their disease, I believe current management is of the same mindset. Amen, brother!!
|
|
|
Post by sellhighdrinklow on May 2, 2019 21:41:56 GMT -5
Where is 60-minutes ? The Mannkind Afrezza story would be a blockbuster ratings booster for them. With the high price of insulin in the news, insulin is on the front burner.
Pay CBS $5 million to run the story.
|
|
|
Post by ktim on May 2, 2019 21:46:12 GMT -5
What we need is like a CEO of a multi billion dollar pharma to get this done. Oh wait hold up just a minute we had one and He gave up in 6 months. It takes more than a name and money to get something like this done. Its called foresight, patience, tenacity,and perseverance. Al Mann had those qualities and I cant think of a better fit to drive this home than Mike. Hes been on this but 2 years and this has done a 180. Our direction is clear as an investor I stand with Al Manns attributes. I had the foresight, ive been patient, and now im going to be tenacious in my stand with Mike in Mannkind. Will discuss persistence when we have won. To me asking for bonuses and raise isn't exactly demonstrating traits of patience and perseverance. There isn't a lot for him to be persevering. He's being treated very well. Would be nice if he were a little more sympathetic and thus forthright with us shareholders that didn't have the foresight to avoid investing in MNKD way too soon, and thus have been forced into patience and perseverance. Perseverance is a great word to describe the long time shareholders actually counting on this as an investment.
|
|